Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Tauns Laboratories, Inc. ( (JP:197A) ).
TAUNS Laboratories, Inc. announced that its shares have been selected as a loan margin trading issue on the Tokyo Stock Exchange, effective June 27, 2025. This designation is expected to enhance liquidity, balance supply and demand, and contribute to establishing fair stock prices, potentially benefiting stakeholders and improving the company’s market position.
More about Tauns Laboratories, Inc.
TAUNS Laboratories, Inc. operates in the pharmaceutical industry, focusing on the development and distribution of medical and laboratory products. The company is listed on the Tokyo Stock Exchange Standard Market.
Average Trading Volume: 662,645
Technical Sentiment Signal: Strong Buy
Learn more about 197A stock on TipRanks’ Stock Analysis page.